Compile Data Set for Download or QSAR
Report error Found 99 Enz. Inhib. hit(s) with all data for entry = 12952
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 6309BDBM6309(8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1...)
Affinity DataIC50: 2.20nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 6309BDBM6309(8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1...)
Affinity DataIC50: 5.80nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744034BDBM744034(US12312355, Compound I-36)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744034BDBM744034(US12312355, Compound I-36)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744034BDBM744034(US12312355, Compound I-36)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744032BDBM744032(N-(4-(4-Ethylpiperazin-1-yl)-3-fluorophe- nyl)-1-i...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744032BDBM744032(N-(4-(4-Ethylpiperazin-1-yl)-3-fluorophe- nyl)-1-i...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744037BDBM744037((4-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quinazo...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744037BDBM744037((4-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quinazo...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744036BDBM744036(N-(4-(2-(Dimethylamino)ethoxy)phenyl)- 1-isopropyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744036BDBM744036(N-(4-(2-(Dimethylamino)ethoxy)phenyl)- 1-isopropyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744036BDBM744036(N-(4-(2-(Dimethylamino)ethoxy)phenyl)- 1-isopropyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744035BDBM744035(N-(4-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quina...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744035BDBM744035(N-(4-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quina...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744035BDBM744035(N-(4-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quina...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744028BDBM744028(1-Isopropyl-N-(2-methoxy-4-(piperazin- 1-yl)phenyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744028BDBM744028(1-Isopropyl-N-(2-methoxy-4-(piperazin- 1-yl)phenyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744028BDBM744028(1-Isopropyl-N-(2-methoxy-4-(piperazin- 1-yl)phenyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744032BDBM744032(N-(4-(4-Ethylpiperazin-1-yl)-3-fluorophe- nyl)-1-i...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744031BDBM744031(N-(3-Fluoro-4-(4-methylpiperazin-1-yl) phenyl)-1-i...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744031BDBM744031(N-(3-Fluoro-4-(4-methylpiperazin-1-yl) phenyl)-1-i...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744031BDBM744031(N-(3-Fluoro-4-(4-methylpiperazin-1-yl) phenyl)-1-i...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744030BDBM744030(N-(3-Fluoro-4-(piperazin-1-yl)phenyl)- 1-isopropyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744030BDBM744030(N-(3-Fluoro-4-(piperazin-1-yl)phenyl)- 1-isopropyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744030BDBM744030(N-(3-Fluoro-4-(piperazin-1-yl)phenyl)- 1-isopropyl...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744038BDBM744038((4-((1-(Isopropyl-1H-[1,2,3]triazolo[4,5- h]quinaz...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744038BDBM744038((4-((1-(Isopropyl-1H-[1,2,3]triazolo[4,5- h]quinaz...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744038BDBM744038((4-((1-(Isopropyl-1H-[1,2,3]triazolo[4,5- h]quinaz...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744037BDBM744037((4-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quinazo...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744009BDBM744009(N-(5-(4-(Dimethylamino)piperidin-1- yl)pyridin-2-y...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744008BDBM744008(N-(5-((4-Ethylpiperazin-1-yl)methyl) pyridin-2-yl)...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744007BDBM744007(N-(5-(4-Isobutylpiperazin-1-yl)pyridin- 2-yl)-1-is...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744007BDBM744007(N-(5-(4-Isobutylpiperazin-1-yl)pyridin- 2-yl)-1-is...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744006BDBM744006(N-(5-(4-Cyclopropylpiperazin-1-yl)py- ridin-2-yl)-...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744005BDBM744005(1-Isopropyl-N-(5-(4-isopropylpiperazin- 1-yl)pyrid...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744013BDBM744013(4-(6-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quina...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744012BDBM744012(1-(6-((1-Isopropyl-1H-[1,2,3]triazolo[4,5- h]quina...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744011BDBM744011(1-Isopropyl-N-(6-(piperazin-1-yl)pyri- dazin-3-yl)...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744010BDBM744010(1-Isopropyl-N-(5-(piperidin-4-yl)pyri- din-2-yl)-1...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744010BDBM744010(1-Isopropyl-N-(5-(piperidin-4-yl)pyri- din-2-yl)-1...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744009BDBM744009(N-(5-(4-(Dimethylamino)piperidin-1- yl)pyridin-2-y...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744001BDBM744001(1-Isopropyl-N-(6-methyl-5-(piperazin- 1-yl)pyridin...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 743999BDBM743999(1-Isopropyl-N-(5-(piperazin-1-yl)pyridin-2-yl)-1H-...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 743999BDBM743999(1-Isopropyl-N-(5-(piperazin-1-yl)pyridin-2-yl)-1H-...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744005BDBM744005(1-Isopropyl-N-(5-(4-isopropylpiperazin- 1-yl)pyrid...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744004BDBM744004(1-Isopropyl-N-(5-morpholinopyridin- 2-yl)-1H-[1,2,...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744003BDBM744003(N-(5-(4-Ethylpiperazin-1-yl)pyridin- 2-yl)-1-isopr...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744003BDBM744003(N-(5-(4-Ethylpiperazin-1-yl)pyridin- 2-yl)-1-isopr...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 6/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744002BDBM744002(1-Isopropyl-N-(5-(4-methylpiperazin- 1-yl)pyridin-...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D3(Human)
Chengdu Cynogen Bio-Pharmaceutical Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 744002BDBM744002(1-Isopropyl-N-(5-(4-methylpiperazin- 1-yl)pyridin-...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compound on the kinase CDK4/cyclin D3 was tested by the Caliper Mobility Shift Assay method. The final test concentratio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/21/2025
Entry Details
US Patent

Displayed 1 to 50 (of 99 total ) | Next | Last >>
Jump to: